Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells

European Journal of Neurology

Volumn 14, Issue 5, 2007, Pages 510-516

  Zhao, J X ^a   Yang, L P ^b   Wang, Y F ^a   Qin, L P ^a   Liu, D Q ^a   Bai, C X ^a   Nan, X ^a   Shi, S S ^a   Pei, X J ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b SOUTHWEST HOSPITAL   (China)

Author keywords

Glioma; Matrix metalloproteinase; Rat

Indexed keywords

GELATINASE A; GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; GLIOMA; GLIOMA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR MODEL; ZYMOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; GLIOMA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RATS; RATS, INBRED F344; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34247150263     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01705.x     Document Type: Article

References (25)

1. Jordan JP, Hand CM, Markowitz RS, Black P. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. Journal of Neuro-oncology 1992; 14: 19-35.
2. Kleiner DE, Stetler-stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemotherapy and Pharmacology 1999; 43: S42-51.
3. Lotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-68.
4. Macdougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progession, invasion and metastasis. Cancer metastasis Reviews 1995; 14: 351-362.
5. Kim SH, Cho NH, Kim K, et al. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. Journal of Surgical Oncology 2006; 93: 330-337.
6. Di GH, Lu JS, Song CG, Li HC, Shen ZZ, Shao ZM. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas. Journal of Experimental & Clinical Cancer Research 2005; 24: 601-667.
7. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in giloma invasion. Frontiers in Bioscience 2003; 1: 261-269.
8. Nakagawa T, Kabuto T, Kabuto M, et al. Production of matrix metalloproteinases abd tissue inhibitor of metalloproteinases-1 by human brain tumors. Journal of Neurooncology 2000; 48: 217-233.
9. Raithatha S, Muzik H, Muzik H, et al. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro-oncology 2000; 2: 145-150.
10. Chitala SK, Tonn JC, Rao JS. Matrix metalloproteinases and their function human gliomas. International Journal of Developmental Neuroscience 1999; 17: 495-502.
11. Forsyth PA, Wong H, Laing TD, et al. Gelatinase-A(MMP-2), gelatinase-B(MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. British Journal of Cancer 1999; 79: 1828-1835.
12. Wheeler KT, Wallen CA. Is cell survival a determinant of the in situ response of 9L tumours? British Journal of Cancer 1980; 41: 299-303.
13. Kim JH, Kim SH, Kolozsvary A, Brown SL, Kim OB, Freytag SO. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents. International Journal of Radiation Oncology, Biology, Physics 1995; 33: 861-868.
14. Lwadate Y, Inoue M, Saegusa T, et al. Recombinant sendai vius vector induces complete remission of established brain tumors though efficient interleukin-2 gene transfer in vaccinated rats. Clinical Cancer Research 2005; 10: 3821-3827.
15. Yamamoto M, Mohanam S, Sawaya R, et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Research 1996; 56: 384-392.
16. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. The Journal of Biological Chemistry 1985; 260: 2493-2500.
17. Takano S, Tsuboi K, Matsumura A, Sato H, Nose T. Localization of gelatinase activity in glioma tissue in situ zymography. Brain Tumor Pathology 2001; 18: 145-150.
18. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type 1 collagen and cell surface matrix metalloproteinase activity. The Journal of Biological Chemistry 2001; 276: 24833-24842.
19. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochemical and Biophysical Research Communications 2003; 308: 386-395.
20. Wang M, Wang T, Liu S, Yoshida D, Teramoto A. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathology 2003; 20: 65-72.
21. Rooprai HK, Van Meter T, Rucklidge GJ, et al. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumors. International Journal of Oncology 1998; 13: 1153-1157.
22. Pagenstecher A, Wussle EM, Opdenakker G, Volk B, Campbell IL. Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors. Journal of Neuropathology and Experimental Neurology 2001; 60: 598-612.
23. Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T, Kobayashi M. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathology 2004; 21: 105-112.
24. Kim MS, Park MJ, Kim SJ, et al. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. International Journal of Oncology 2005; 27: 839-846.
25. Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fujii Y. Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography. European Journal of Cancer 2000; 36: 2164-2170.